Literature DB >> 26335719

Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections.

Kelly J Pittman1, Laura J Knoll2.   

Abstract

Toxoplasma gondii represents one of the most common parasitic infections in the world. The asexual cycle can occur within any warm-blooded animal, but the sexual cycle is restricted to the feline intestinal epithelium. T. gondii is acquired through consumption of tissue cysts in undercooked meat as well as food and water contaminated with oocysts. Once ingested, it differentiates into a rapidly replicating asexual form and disseminates throughout the body during acute infection. After stimulation of the host immune response, T. gondii differentiates into a slow-growing, asexual cyst form that is the hallmark of chronic infection. One-third of the human population is chronically infected with T. gondii cysts, which can reactivate and are especially dangerous to individuals with reduced immune surveillance. Serious complications can also occur in healthy individuals if infected with certain T. gondii strains or if infection is acquired congenitally. No drugs are available to clear the cyst form during the chronic stages of infection. This therapeutic gap is due in part to an incomplete understanding of both host and pathogen responses during the progression of T. gondii infection. While many individual aspects of T. gondii infection are well understood, viewing the interconnections between host and parasite during acute and chronic infection may lead to better approaches for future treatment. The aim of this review is to provide an overview of what is known and unknown about the complex relationship between the host and parasite during the progression of T. gondii infection, with the ultimate goal of bridging these events.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26335719      PMCID: PMC4557073          DOI: 10.1128/MMBR.00027-15

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  173 in total

1.  Differential gene expression in mice infected with distinct Toxoplasma strains.

Authors:  Rachel D Hill; Julia S Gouffon; Arnold M Saxton; Chunlei Su
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  A patatin-like protein protects Toxoplasma gondii from degradation in a nitric oxide-dependent manner.

Authors:  Crystal M Tobin; Laura J Knoll
Journal:  Infect Immun       Date:  2011-10-17       Impact factor: 3.441

3.  Identification of tissue cyst wall components by transcriptome analysis of in vivo and in vitro Toxoplasma gondii bradyzoites.

Authors:  Kerry R Buchholz; Heather M Fritz; Xiucui Chen; Blythe Durbin-Johnson; David M Rocke; David J Ferguson; Patricia A Conrad; John C Boothroyd
Journal:  Eukaryot Cell       Date:  2011-10-21

4.  Reassessment of the role of aromatic amino acid hydroxylases and the effect of infection by Toxoplasma gondii on host dopamine.

Authors:  Zi T Wang; Steve Harmon; Karen L O'Malley; L David Sibley
Journal:  Infect Immun       Date:  2014-12-29       Impact factor: 3.441

5.  Toxoplasmosis and pregnancy.

Authors:  Shahnaz Akhtar Chaudhry; Nanette Gad; Gideon Koren
Journal:  Can Fam Physician       Date:  2014-04       Impact factor: 3.275

6.  Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes.

Authors:  Adrian B Hehl; Walter U Basso; Christoph Lippuner; Chandra Ramakrishnan; Michal Okoniewski; Robert A Walker; Michael E Grigg; Nicholas C Smith; Peter Deplazes
Journal:  BMC Genomics       Date:  2015-02-13       Impact factor: 3.969

7.  Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination.

Authors:  Kirk D C Jensen; Ana Camejo; Mariane B Melo; Cynthia Cordeiro; Lindsay Julien; Gijsbert M Grotenbreg; Eva-Maria Frickel; Hidde L Ploegh; Lucy Young; Jeroen P J Saeij
Journal:  mBio       Date:  2015-02-24       Impact factor: 7.867

8.  Toxoplasma gondii profilin promotes recruitment of Ly6Chi CCR2+ inflammatory monocytes that can confer resistance to bacterial infection.

Authors:  Lori M Neal; Laura J Knoll
Journal:  PLoS Pathog       Date:  2014-06-12       Impact factor: 6.823

9.  Efficient gene disruption in diverse strains of Toxoplasma gondii using CRISPR/CAS9.

Authors:  Bang Shen; Kevin M Brown; Tobie D Lee; L David Sibley
Journal:  mBio       Date:  2014-05-13       Impact factor: 7.867

10.  Dual transcriptional profiling of mice and Toxoplasma gondii during acute and chronic infection.

Authors:  Kelly J Pittman; Matthew T Aliota; Laura J Knoll
Journal:  BMC Genomics       Date:  2014-09-20       Impact factor: 3.969

View more
  27 in total

1.  Reexamining Chronic Toxoplasma gondii Infection: Surprising Activity for a "Dormant" Parasite.

Authors:  Anthony P Sinai; Elizabeth A Watts; Animesh Dhara; Robert D Murphy; Matthew S Gentry; Abhijit Patwardhan
Journal:  Curr Clin Microbiol Rep       Date:  2016-10-04

Review 2.  Toxoplasma gondii-A Gastrointestinal Pathogen Associated with Human Brain Diseases.

Authors:  E G Severance; J Xiao; L Jones-Brando; S Sabunciyan; Y Li; M Pletnikov; E Prandovszky; R Yolken
Journal:  Int Rev Neurobiol       Date:  2016-10-04       Impact factor: 3.230

3.  Secreted protein kinases regulate cyst burden during chronic toxoplasmosis.

Authors:  Nathaniel G Jones; Qiuling Wang; L David Sibley
Journal:  Cell Microbiol       Date:  2016-08-25       Impact factor: 3.715

Review 4.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

5.  Toxoplasma invasion delayed by TgERK7 eradication.

Authors:  Zhong-Yuan Li; Xue Liang; Hai-Ting Guo; Jie Tan; Xing-Quan Zhu; Quan Liu
Journal:  Parasitol Res       Date:  2020-09-11       Impact factor: 2.289

Review 6.  Vaccines in Congenital Toxoplasmosis: Advances and Perspectives.

Authors:  Mariana Barros; Daniela Teixeira; Manuel Vilanova; Alexandra Correia; Natercia Teixeira; Margarida Borges
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 7.561

7.  Simultaneous transcriptional profiling of Leishmania major and its murine macrophage host cell reveals insights into host-pathogen interactions.

Authors:  Laura A L Dillon; Rahul Suresh; Kwame Okrah; Hector Corrada Bravo; David M Mosser; Najib M El-Sayed
Journal:  BMC Genomics       Date:  2015-12-29       Impact factor: 3.969

8.  Macrophages Polarized by Expression of ToxoGRA15II Inhibit Growth of Hepatic Carcinoma.

Authors:  Yuanling Li; Faustina Poppoe; Jian Chen; Li Yu; Fang Deng; Qingli Luo; Yuanhong Xu; Yihong Cai; Jilong Shen
Journal:  Front Immunol       Date:  2017-02-13       Impact factor: 7.561

9.  Activation of chronic toxoplasmosis by transportation stress in a mouse model.

Authors:  Bang Shen; Yuan Yuan; Jianxi Cheng; Ming Pan; Ningbo Xia; Weichao Zhang; Yifan Wang; Yanqin Zhou; Junlong Zhao
Journal:  Oncotarget       Date:  2016-12-27

10.  Caspase-11 Modulates Inflammation and Attenuates Toxoplasma gondii Pathogenesis.

Authors:  Sheryl L Coutermarsh-Ott; John T Doran; Caroline Campbell; Tere M Williams; David S Lindsay; Irving C Allen
Journal:  Mediators Inflamm       Date:  2016-06-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.